$ORC
Orchid Island Capital, Inc.

2021 Q4 Form 10-Q Financial Statement

#000151862121000143 Filed on October 29, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue -$38.18M $34.17M $27.22M
YoY Change -279.31% 25.52% -24.18%
Cost Of Revenue $4.610M $3.726M $3.300M
YoY Change 35.59% 12.91% -86.11%
Gross Profit -$42.79M $27.56M $29.67M
YoY Change -339.16% -7.13% -507.0%
Gross Profit Margin 80.65% 108.99%
Selling, General & Admin $1.327M $3.674M $2.849M
YoY Change 9.67% 28.96% 8.24%
% of Gross Profit 13.33% 9.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.778M $3.674M $2.849M
YoY Change 26.1% 28.96% 8.24%
Operating Profit -$44.56M $23.88M $26.82M
YoY Change -370.41% -10.96% -370.32%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.220M
YoY Change 45.07%
Pretax Income -$44.56M $26.04M $28.08M
YoY Change -370.41% -7.27% -431.13%
Income Tax
% Of Pretax Income
Net Earnings -$44.56M $26.04M $28.08M
YoY Change -370.43% -7.26% -431.2%
Net Earnings / Revenue 76.2% 103.13%
Basic Earnings Per Share $0.20 $0.42
Diluted Earnings Per Share -$264.2K $0.20 $0.42
COMMON SHARES
Basic Shares Outstanding 161.2M shares 123.1M shares 66.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $385.1M $424.1M $199.8M
YoY Change 74.99% 112.28% 35.55%
Cash & Equivalents $385.1M $424.1M $199.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00 $0.00 $0.00
Other Receivables $18.86M $15.24M $10.40M
Total Short-Term Assets $404.0M $439.4M $210.2M
YoY Change 75.5% 109.03% -43.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $6.548B $5.639B $3.540B
YoY Change 75.7% 59.27% -7.34%
Other Assets $65.30M $51.11M $47.50M
YoY Change 11.05% 7.6% 75.28%
Total Long-Term Assets $6.665B $5.738B $3.603B
YoY Change 74.11% 59.26% -7.15%
TOTAL ASSETS
Total Short-Term Assets $404.0M $439.4M $210.2M
Total Long-Term Assets $6.665B $5.738B $3.603B
Total Assets $7.069B $6.177B $3.813B
YoY Change 74.19% 62.0% -10.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.062M $935.0K $600.0K
YoY Change 77.0% 55.83% 0.0%
Accrued Expenses $788.0K $753.0K $800.0K
YoY Change -34.33% -5.88% -93.28%
Deferred Revenue
YoY Change
Short-Term Debt $6.244B $5.214B $3.281B
YoY Change 73.66% 58.9% -13.97%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.257B $5.406B $3.401B
YoY Change 73.7% 58.96% -11.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $43.09M $40.35M $35.40M
YoY Change 6.67% 13.97% 18.79%
Total Long-Term Liabilities $43.09M $40.35M $35.40M
YoY Change 6.67% 13.97% 18.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.257B $5.406B $3.401B
Total Long-Term Liabilities $43.09M $40.35M $35.40M
Total Liabilities $6.301B $5.447B $3.436B
YoY Change 72.96% 58.5% -11.01%
SHAREHOLDERS EQUITY
Retained Earnings -$82.75M -$38.19M -$34.47M
YoY Change 359.9% 10.78% -11.0%
Common Stock $354.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $768.1M $730.6M $376.7M
YoY Change
Total Liabilities & Shareholders Equity $7.069B $6.177B $3.813B
YoY Change 74.19% 62.0% -10.35%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$44.56M $26.04M $28.08M
YoY Change -370.43% -7.26% -431.2%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $35.26M $22.53M $18.82M
YoY Change 43.96% 19.74% 113.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$1.174B -$779.1M -$117.6M
YoY Change 279.75% 562.66% -77.11%
Cash From Investing Activities -$1.174B -$779.1M -$117.6M
YoY Change 279.75% 562.66% -77.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.114B 852.1M 110.1M
YoY Change 230.71% 674.13% -79.07%
NET CHANGE
Cash From Operating Activities 35.26M 22.53M 18.82M
Cash From Investing Activities -1.174B -779.1M -117.6M
Cash From Financing Activities 1.114B 852.1M 110.1M
Net Change In Cash -24.80M 95.53M 11.32M
YoY Change -147.55% 743.87% -46.4%
FREE CASH FLOW
Cash From Operating Activities $35.26M $22.53M $18.82M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
dei Amendment Flag
AmendmentFlag
false
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153318351 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76073317 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001518621
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Shell Company
EntityShellCompany
false
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35236
dei Entity Registrant Name
EntityRegistrantName
Orchid Island Capital, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3269228
dei Entity Address Address Line1
EntityAddressAddressLine1
3305 Flamingo Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Vero Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32963
dei City Area Code
CityAreaCode
772
dei Local Phone Number
LocalPhoneNumber
231-1400
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
ORC
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
161157349 shares
CY2021Q3 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
5601423000 USD
CY2021Q3 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
37409000 USD
CY2020Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
424133000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
51111000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
79363000 USD
CY2021Q3 us-gaap Interest Receivable
InterestReceivable
15241000 USD
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
9721000 USD
CY2021Q3 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
47383000 USD
CY2020Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
20999000 USD
CY2021Q3 us-gaap Other Receivables From Broker Dealers And Clearing Organizations
OtherReceivablesFromBrokerDealersAndClearingOrganizations
0 USD
CY2020Q4 us-gaap Other Receivables From Broker Dealers And Clearing Organizations
OtherReceivablesFromBrokerDealersAndClearingOrganizations
414000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
516000 USD
CY2020Q4 us-gaap Assets
Assets
4058051000 USD
CY2021Q3 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
5213869000 USD
CY2020Q4 us-gaap Securities Sold Under Agreements To Repurchase
SecuritiesSoldUnderAgreementsToRepurchase
3595586000 USD
CY2021Q3 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
180619000 USD
CY2020Q4 us-gaap Other Payables To Broker Dealers And Clearing Organizations
OtherPayablesToBrokerDealersAndClearingOrganizations
0 USD
CY2021Q3 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
9991000 USD
CY2020Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
4970000 USD
CY2021Q3 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
10288000 USD
CY2020Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
33227000 USD
CY2021Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
935000 USD
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
30058000 USD
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
7188000 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153318351 shares
CY2021Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1533000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
432524000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38190000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17994000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
730629000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6177142000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
90279000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
90152000 USD
CY2021Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
34169000 USD
CY2020Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
27223000 USD
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
5067000 USD
us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
23045000 USD
CY2021Q3 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
1570000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
85212000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
67107000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25180000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-3068000 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-24522000 USD
CY2021Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
2977000 USD
CY2020Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
498000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
38440000 USD
CY2021Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-11239000 USD
CY2020Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1168000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
15932000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-87630000 USD
CY2021Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
5375000 USD
CY2020Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
4079000 USD
orc Net Portfolio Income
NetPortfolioIncome
-6605000 USD
CY2021Q3 orc Net Portfolio Income
NetPortfolioIncome
29712000 USD
CY2020Q3 orc Net Portfolio Income
NetPortfolioIncome
30925000 USD
CY2021Q3 us-gaap Management Fee Expense
ManagementFeeExpense
2156000 USD
CY2020Q3 us-gaap Management Fee Expense
ManagementFeeExpense
1252000 USD
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1189000 USD
us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
1072000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
390000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold Overhead
CostOfGoodsAndServicesSoldOverhead
377000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
884000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
-117000 USD
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
259000 USD
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
158000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
874000 USD
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
750000 USD
CY2021Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
279000 USD
CY2020Q3 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
242000 USD
us-gaap Professional Fees
ProfessionalFees
832000 USD
us-gaap Professional Fees
ProfessionalFees
841000 USD
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
212000 USD
CY2020Q3 us-gaap Professional Fees
ProfessionalFees
240000 USD
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
1024000 USD
orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
852000 USD
CY2021Q3 orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
309000 USD
CY2020Q3 orc Direct Reit Operating Expenses
DirectReitOperatingExpenses
406000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
514000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
451000 USD
CY2021Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
69000 USD
CY2020Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
174000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
10886000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7746000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3674000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2849000 USD
us-gaap Profit Loss
ProfitLoss
-20196000 USD
us-gaap Profit Loss
ProfitLoss
-14351000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
26038000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
28076000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67301901 shares
CY2021Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.195
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.190
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63062000 shares
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
395507000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-91199000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-91199000 USD
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
20000 shares
CY2020Q2 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-68000 USD
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66221000 shares
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
345968000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
28076000 USD
CY2020Q3 us-gaap Dividends
Dividends
12920000 USD
CY2020Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3073000 shares
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3171000 shares
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19447000 USD
CY2020Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
4000 shares
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
59000 USD
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
66237000 shares
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
308144000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
48772000 USD
CY2020Q2 us-gaap Dividends
Dividends
10935000 USD
CY2020Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
4000 shares
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
90000 shares
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
572000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-10349000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-2031000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
16000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15566000 USD
CY2020Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2000 shares
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
51000 USD
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69296000 shares
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
376741000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-29369000 USD
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
18248000 shares
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
96908000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
466176000 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-16865000 USD
CY2021Q2 us-gaap Dividends
Dividends
20416000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
23087000 shares
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
124746000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
2000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
117500000 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
553821000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
26038000 USD
CY2021Q3 us-gaap Dividends
Dividends
26420000 USD
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
35818000 shares
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
177007000 USD
CY2021Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
0 shares
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
183000 USD
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153318000 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
730629000 USD
us-gaap Profit Loss
ProfitLoss
-20196000 USD
us-gaap Profit Loss
ProfitLoss
-14351000 USD
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
167000 USD
us-gaap Gain Loss On Investments Excluding Other Than Temporary Impairments
GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
13918000 USD
orc Fair Value Adjustments On Us Treasury Notes
FairValueAdjustmentsOnUsTreasuryNotes
-31000 USD
orc Fair Value Adjustments On Us Treasury Notes
FairValueAdjustmentsOnUsTreasuryNotes
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
22180000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-67744000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
5449000 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2137000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
2898616000 USD
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
2598893000 USD
orc Proceeds From Sale Of Mortgage Backed Securities Mbs Categorized As Trading
ProceedsFromSaleOfMortgageBackedSecuritiesMbsCategorizedAsTrading
2692230000 USD
orc Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Categorized As Trading
ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesCategorizedAsTrading
413005000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
37440000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
0 USD
us-gaap Interest Paid Net
InterestPaidNet
5471000 USD
us-gaap Proceeds From Payments For Securities Purchased Under Agreements To Resell
ProceedsFromPaymentsForSecuritiesPurchasedUnderAgreementsToResell
30000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
1228000 USD
us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
68223000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1843071000 USD
orc Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
27995556000 USD
orc Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
21376997000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
40065000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
398661000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35013000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
299000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
70000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1957626000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-171925000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
175738000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-31309000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299506000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278655000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
475244000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247346000 USD
us-gaap Interest Paid Net
InterestPaidNet
33395000 USD
CY2021Q3 orc Securities Acquisitions Settled In Later Period
SecuritiesAcquisitionsSettledInLaterPeriod
180619000 USD
CY2020Q3 orc Securities Acquisitions Settled In Later Period
SecuritiesAcquisitionsSettledInLaterPeriod
113653000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div id="TextBlockContainer7" style="position:relative;font-family:'Arial Narrow';font-size:14.72px;font-stretch:condensed;color:#000000;line-height:normal;width:733px;height:114px;display:inline-block;border:inherit;margin-left:-2px;margin-right:-2px;"><div id="a2405" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:28px;top:0px;">The preparation<div style="display:inline-block;width:1px"> </div>of financial<div style="display:inline-block;width:1px"> </div>statements<div style="display:inline-block;width:2px"> </div>in conformity<div style="display:inline-block;width:1px"> </div>with GAAP<div style="display:inline-block;width:1px"> </div>requires<div style="display:inline-block;width:2px"> </div>management<div style="display:inline-block;width:2px"> </div>to make estimates<div style="display:inline-block;width:1px"> </div>and assumptions<div style="display:inline-block;width:1px"> </div>that affect </div><div id="a2407" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:19px;">the reported<div style="display:inline-block;width:1px"> </div>amounts of<div style="display:inline-block;width:2px"> </div>assets and<div style="display:inline-block;width:2px"> </div>liabilities<div style="display:inline-block;width:2px"> </div>and disclosure<div style="display:inline-block;width:1px"> </div>of contingent<div style="display:inline-block;width:1px"> </div>assets and<div style="display:inline-block;width:2px"> </div>liabilities<div style="display:inline-block;width:1px"> </div>at the date<div style="display:inline-block;width:1px"> </div>of the financial<div style="display:inline-block;width:1px"> </div>statements<div style="display:inline-block;width:2px"> </div>and </div><div id="a2409" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:39px;">the reported<div style="display:inline-block;width:1px"> </div>amounts of<div style="display:inline-block;width:2px"> </div>revenues<div style="display:inline-block;width:2px"> </div>and expenses<div style="display:inline-block;width:1px"> </div>during the<div style="display:inline-block;width:2px"> </div>reporting<div style="display:inline-block;width:2px"> </div>period. Actual<div style="display:inline-block;width:1px"> </div>results could<div style="display:inline-block;width:1px"> </div>differ from<div style="display:inline-block;width:2px"> </div>those estimates.<div style="display:inline-block;width:4px"> </div>The </div><div id="a2412" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:58px;">significant<div style="display:inline-block;width:2px"> </div>estimates<div style="display:inline-block;width:2px"> </div>affecting the<div style="display:inline-block;width:1px"> </div>accompanying<div style="display:inline-block;width:2px"> </div>financial<div style="display:inline-block;width:2px"> </div>statements<div style="display:inline-block;width:2px"> </div>are the fair<div style="display:inline-block;width:1px"> </div>values of<div style="display:inline-block;width:2px"> </div>RMBS and<div style="display:inline-block;width:2px"> </div>derivatives.<div style="display:inline-block;width:2px"> </div>Management<div style="display:inline-block;width:2px"> </div>believes </div><div id="a2416" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:77px;">the estimates<div style="display:inline-block;width:1px"> </div>and assumptions<div style="display:inline-block;width:1px"> </div>underlying<div style="display:inline-block;width:2px"> </div>the financial<div style="display:inline-block;width:1px"> </div>statements<div style="display:inline-block;width:2px"> </div>are reasonable<div style="display:inline-block;width:1px"> </div>based on<div style="display:inline-block;width:2px"> </div>the information<div style="display:inline-block;width:1px"> </div>available<div style="display:inline-block;width:2px"> </div>as of September<div style="display:inline-block;width:1px"> </div>30, </div><div id="a2418" style="position:absolute;font-family:'Arial Narrow';font-size:14.72px;font-weight:normal;font-style:normal;font-stretch:condensed;color:#000000;left:4px;top:97px;">2021.</div></div>
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
424133000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
51111000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
79363000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
475244000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299506000 USD
CY2021Q3 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
5601423000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
15932000 USD
us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
-87630000 USD
CY2021Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
5375000 USD
CY2020Q3 us-gaap Gain Loss On Derivative Instruments Held For Trading Purposes Net
GainLossOnDerivativeInstrumentsHeldForTradingPurposesNet
4079000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
51111000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
79363000 USD
CY2021Q3 orc Securities Pledged By Counterparties
SecuritiesPledgedByCounterparties
18763000 USD
CY2020Q4 orc Securities Pledged By Counterparties
SecuritiesPledgedByCounterparties
6456000 USD
CY2021Q3 orc Gross Amount Of Recognized Assets
GrossAmountOfRecognizedAssets
47383000 USD
CY2021Q3 orc Gross Amount Of Assets Offset In The Balance Sheet
GrossAmountOfAssetsOffsetInTheBalanceSheet
0 USD
CY2021Q3 orc Net Amount Of Assets Presented In The Balance Sheet
NetAmountOfAssetsPresentedInTheBalanceSheet
47383000 USD
CY2021Q3 orc Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet
GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet
0 USD
CY2021Q3 orc Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet
GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet
-13765000 USD
CY2021Q3 orc Net Amount Of Assets
NetAmountOfAssets
33618000 USD
CY2020Q4 orc Gross Amount Of Recognized Assets
GrossAmountOfRecognizedAssets
20999000 USD
CY2020Q4 orc Gross Amount Of Assets Offset In The Balance Sheet
GrossAmountOfAssetsOffsetInTheBalanceSheet
0 USD
CY2020Q4 orc Net Amount Of Assets Presented In The Balance Sheet
NetAmountOfAssetsPresentedInTheBalanceSheet
20999000 USD
CY2020Q4 orc Gross Amounts Of Financial Instruments Received Not Offset In Balance Sheet
GrossAmountsOfFinancialInstrumentsReceivedNotOffsetInBalanceSheet
0 USD
CY2020Q4 orc Gross Amounts Of Cash Collateral Received Not Offset In Balance Sheet
GrossAmountsOfCashCollateralReceivedNotOffsetInBalanceSheet
-6083000 USD
CY2020Q4 orc Net Amount Of Assets
NetAmountOfAssets
14916000 USD
CY2021Q3 orc Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2021Q3 orc Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-48636000 USD
CY2020Q4 orc Gross Amount Of Recognized Liabilties
GrossAmountOfRecognizedLiabilties
3628813000 USD
CY2020Q4 orc Gross Amount Of Liabilties Offset In The Balance Sheet
GrossAmountOfLiabiltiesOffsetInTheBalanceSheet
0 USD
CY2020Q4 orc Net Amount Of Liabilities Presented In The Balance Sheet
NetAmountOfLiabilitiesPresentedInTheBalanceSheet
3628813000 USD
CY2020Q4 orc Gross Amount Of Financial Instruments Posted Not Offset In Balance Sheet
GrossAmountOfFinancialInstrumentsPostedNotOffsetInBalanceSheet
-3536757000 USD
CY2020Q4 orc Gross Amounts Of Cash Posted Not Offset In Balance Sheet
GrossAmountsOfCashPostedNotOffsetInBalanceSheet
-78874000 USD
CY2020Q4 orc Net Amount Of Liabilities
NetAmountOfLiabilities
13182000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
398661000 USD
CY2020 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
13019240 shares
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
71050000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
7366623 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20196000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20196000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-14351000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-14351000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
266000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
87000 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
26038000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
28076000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
28076000 USD
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
153318000 shares
orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
69296000 shares
CY2021Q3 orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
153318000 shares
CY2020Q3 orc Common Shares Outstanding Earnings Per Share
CommonSharesOutstandingEarningsPerShare
69296000 shares
orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
0 shares
orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
0 shares
CY2021Q3 orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
266000 shares
CY2020Q3 orc Unvested Dividend Eligible Shares Outstanding Earnings Per Share
UnvestedDividendEligibleSharesOutstandingEarningsPerShare
87000 shares
orc Effect Of Weighting
EffectOfWeighting
-48012000 shares
orc Effect Of Weighting
EffectOfWeighting
-3282000 shares
CY2020Q3 orc Effect Of Weighting
EffectOfWeighting
-2081000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
105306000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66014000 shares
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67302000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19

Files In Submission

Name View Source Status
0001518621-21-000143-index-headers.html Edgar Link pending
0001518621-21-000143-index.html Edgar Link pending
0001518621-21-000143.txt Edgar Link pending
0001518621-21-000143-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
orc-20210930.xsd Edgar Link pending
orc-20210930_cal.xml Edgar Link unprocessable
orc-20210930_def.xml Edgar Link unprocessable
orc-20210930_lab.xml Edgar Link unprocessable
orc-20210930_pre.xml Edgar Link unprocessable
orc10q20210930.htm Edgar Link pending
orc10q20210930p1i0.gif Edgar Link pending
orc10q20210930x311.htm Edgar Link pending
orc10q20210930x312.htm Edgar Link pending
orc10q20210930x321.htm Edgar Link pending
orc10q20210930x322.htm Edgar Link pending
orc10q20210930_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending